Pistis, Marco
Pistis, Marco
Istituto di Neuroscienze - IN - Sede Secondaria Monserrato (CA)
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus
2024 Sagheddu, Claudia; Stojanovic, Tamara; Kouhnavardi, Shima; Savchenko, Artem; Hussein, Ahmed M.; Pistis, Marco; Monje, Francisco J.; Plasenzotti, Roberto; Aufy, Mohammed; Studenik, Christian R.; Lubec, Jana; Lubec, Gert
Functional Adaptation in the Brain Habenulo–Mesencephalic Pathway During Cannabinoid Withdrawal
2024 Aroni, S.; Sagheddu, C.; Pistis, M.; Muntoni, A. L.
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug‐resistant epilepsy (DRE)
2024 Manca, Claudia; Coa, Roberta; Murru, Elisabetta; Carta, Gianfranca; Pinna, Giovanni; Sanfilippo, Roberto; Polizzi, Lorenzo; Pistis, Marco; Follesa, Paolo; Puligheddu, Monica; Banni, Sebastiano
Maternal Immune Activation and the Endocannabinoid System: Focus on Two-Hit Models of Schizophrenia
2024 Santoni, Michele; Pistis, Marco
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring
2023 Santoni, M.; Sagheddu, C.; Serra, V.; Mostallino, R.; Castelli, M. P.; Pisano, F.; Scherma, M.; Fadda, P.; Muntoni, A. L.; Zamberletti, E.; Rubino, T.; Melis, M.; Pistis, M.
The Atypical Dopamine Transporter Inhibitor CE-158 Enhances Dopamine Neurotransmission in the Prefrontal Cortex of Male Rats: A Behavioral, Electrophysiological, and Microdialysis Study
2023 Sagheddu, C.; Cancedda, E.; Bagheri, F.; Kalaba, P.; Muntoni, A. L.; Lubec, J.; Lubec, G.; Sanna, F.; Pistis, M.
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPAR-alpha Agonist Fenofibrate-Treated Mice
2022 Murru, Elisabetta; Muntoni, ANNA LISA; Manca, Claudia; Aroni, Sonia; Pistis, Marco; Banni, Sebastiano; Carta, Gianfranca
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance
2021 Congiu, M; Micheli, L; Santoni, M; Sagheddu, C; Muntoni, Al; Makriyannis, A; Malamas, Ms; Ghelardini, C; Di Cesare Mannelli, L; Pistis, M
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates
2021 Pintori, N; Castelli, Mp; Miliano, C; Simola, N; Fadda, P; Fattore, L; Scherma, M; Ennas, Mg; Mostallino, R; Flore, G; De Felice, M; Sagheddu, C; Pistis, M; Di Chiara, G; De Luca, Ma
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders
2021 Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M
delta 9 Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation
2019 Lecca, Salvatore; Luchicchi, Antonio; Scherma, Maria; Fadda, Paola; Muntoni, ANNA LISA; Pistis, Marco
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice
2019 Torres, Lh; Balestrin, Nt; Spelta, Lew; Duro, Sdo; Pistis, M; Marcourakis, T
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward
2019 Sagheddu, C; Scherma, M; Congiu, M; Fadda, P; Carta, G; Banni, S; Wood, Jt; Makriyannis, A; Malamas, Ms; Pistis, M
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding
2019 Rotolo R.A.; Dragacevic V.; Kalaba P.; Urban E.; Zehl M.; Roller A.; Wackerlig J.; Langer T.; Pistis M.; De Luca M.A.; Caria F.; Schwartz R.; Presby R.E.; Yang J.H.; Samels S.; Correa M.; Lubec G.; Salamone J.D.
The PPAR alpha agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia
2019 De Felice, Marta; Melis, Miriam; Aroni, Sonia; Muntoni, Anna Lisa; Fanni, Silvia; Frau, Roberto; Devoto, Paola; Pistis, Marco
Oltre gli endocannabinoidi: ruolo dei neuromodulatori lipidici nelle tossicodipendenze
2018 Congiu, M; Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy
2017 Puligheddu, M; Melis, M; Pillolla, G; Milioli, G; Parrino, L; Terzano, Gm; Aroni, S; Sagheddu, C; Marrosu, F; Pistis, M; Muntoni, Al
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases
2017 Pistis M.; Muntoni A.L.
Adolescent D9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats
2016 Scherma, M.; Dessì, C.; Muntoni, A.L.; Lecca, S.; Satta, V.; Luchicchi, L.; Pistis, M.; Panlilio, L.V.; Fattore, L.; Goldberg, S.R.; Fratta, W.; Fadda, P.
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives
2016 Scherma M.; Muntoni A.L.; Melis M.; Fattore L.; Fadda P.; Fratta W.; Pistis M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus | 1-gen-2024 | Sagheddu, Claudia; Stojanovic, Tamara; Kouhnavardi, Shima; Savchenko, Artem; Hussein, Ahmed M.; Pistis, Marco; Monje, Francisco J.; Plasenzotti, Roberto; Aufy, Mohammed; Studenik, Christian R.; Lubec, Jana; Lubec, Gert | |
Functional Adaptation in the Brain Habenulo–Mesencephalic Pathway During Cannabinoid Withdrawal | 1-gen-2024 | Aroni, S.; Sagheddu, C.; Pistis, M.; Muntoni, A. L. | |
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug‐resistant epilepsy (DRE) | 1-gen-2024 | Manca, Claudia; Coa, Roberta; Murru, Elisabetta; Carta, Gianfranca; Pinna, Giovanni; Sanfilippo, Roberto; Polizzi, Lorenzo; Pistis, Marco; Follesa, Paolo; Puligheddu, Monica; Banni, Sebastiano | |
Maternal Immune Activation and the Endocannabinoid System: Focus on Two-Hit Models of Schizophrenia | 1-gen-2024 | Santoni, Michele; Pistis, Marco | |
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring | 1-gen-2023 | Santoni, M.; Sagheddu, C.; Serra, V.; Mostallino, R.; Castelli, M. P.; Pisano, F.; Scherma, M.; Fadda, P.; Muntoni, A. L.; Zamberletti, E.; Rubino, T.; Melis, M.; Pistis, M. | |
The Atypical Dopamine Transporter Inhibitor CE-158 Enhances Dopamine Neurotransmission in the Prefrontal Cortex of Male Rats: A Behavioral, Electrophysiological, and Microdialysis Study | 1-gen-2023 | Sagheddu, C.; Cancedda, E.; Bagheri, F.; Kalaba, P.; Muntoni, A. L.; Lubec, J.; Lubec, G.; Sanna, F.; Pistis, M. | |
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPAR-alpha Agonist Fenofibrate-Treated Mice | 1-gen-2022 | Murru, Elisabetta; Muntoni, ANNA LISA; Manca, Claudia; Aroni, Sonia; Pistis, Marco; Banni, Sebastiano; Carta, Gianfranca | |
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance | 1-gen-2021 | Congiu, M; Micheli, L; Santoni, M; Sagheddu, C; Muntoni, Al; Makriyannis, A; Malamas, Ms; Ghelardini, C; Di Cesare Mannelli, L; Pistis, M | |
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates | 1-gen-2021 | Pintori, N; Castelli, Mp; Miliano, C; Simola, N; Fadda, P; Fattore, L; Scherma, M; Ennas, Mg; Mostallino, R; Flore, G; De Felice, M; Sagheddu, C; Pistis, M; Di Chiara, G; De Luca, Ma | |
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders | 1-gen-2021 | Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M | |
delta 9 Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation | 1-gen-2019 | Lecca, Salvatore; Luchicchi, Antonio; Scherma, Maria; Fadda, Paola; Muntoni, ANNA LISA; Pistis, Marco | |
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice | 1-gen-2019 | Torres, Lh; Balestrin, Nt; Spelta, Lew; Duro, Sdo; Pistis, M; Marcourakis, T | |
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward | 1-gen-2019 | Sagheddu, C; Scherma, M; Congiu, M; Fadda, P; Carta, G; Banni, S; Wood, Jt; Makriyannis, A; Malamas, Ms; Pistis, M | |
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding | 1-gen-2019 | Rotolo R.A.; Dragacevic V.; Kalaba P.; Urban E.; Zehl M.; Roller A.; Wackerlig J.; Langer T.; Pistis M.; De Luca M.A.; Caria F.; Schwartz R.; Presby R.E.; Yang J.H.; Samels S.; Correa M.; Lubec G.; Salamone J.D. | |
The PPAR alpha agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia | 1-gen-2019 | De Felice, Marta; Melis, Miriam; Aroni, Sonia; Muntoni, Anna Lisa; Fanni, Silvia; Frau, Roberto; Devoto, Paola; Pistis, Marco | |
Oltre gli endocannabinoidi: ruolo dei neuromodulatori lipidici nelle tossicodipendenze | 1-gen-2018 | Congiu, M; Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M | |
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy | 1-gen-2017 | Puligheddu, M; Melis, M; Pillolla, G; Milioli, G; Parrino, L; Terzano, Gm; Aroni, S; Sagheddu, C; Marrosu, F; Pistis, M; Muntoni, Al | |
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases | 1-gen-2017 | Pistis M.; Muntoni A.L. | |
Adolescent D9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats | 1-gen-2016 | Scherma, M.; Dessì, C.; Muntoni, A.L.; Lecca, S.; Satta, V.; Luchicchi, L.; Pistis, M.; Panlilio, L.V.; Fattore, L.; Goldberg, S.R.; Fratta, W.; Fadda, P. | |
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives | 1-gen-2016 | Scherma M.; Muntoni A.L.; Melis M.; Fattore L.; Fadda P.; Fratta W.; Pistis M. |